FOSTER ALAN CHARLES (Chief Scientific Officer) sold 2.4% of their position (4.39K shares) of OTONOMY, INC. on the open market
Open‑market sale worth $10.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/29/2022ACC: 0001209191-22-021546
Officer· Chief Scientific Officer
Since Apr 2021
-4.39K
Net shares
Net seller
$10.5K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
4.39K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.83K
Price / share
$2.39
Trade value
$4.36K
% of position
1.0%
3/25/2022
181.40K→179.58K
Common Stock
Direct
Shares
−2.56K
Price / share
$2.41
Trade value
$6.17K
% of position
1.4%
3/28/2022
179.58K→177.02K
Total
Net shares
−4.39K
Net value
-$10.54K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/25/2022 | S · Sale | −1.83K | $2.39 | $4.36K | 1.0% | 181.40K | 179.58K |
| Common Stock Direct | 3/28/2022 | S · Sale | −2.56K | $2.41 | $6.17K | 1.4% | 179.58K | 177.02K |
| Total | −4.39K | -$10.54K | ||||||
Derivative Transactions0
No derivative transactions reported